Jiandi Wan

Title: Innovations in Cancer Treatment by Jiandi Wan

Introduction

Jiandi Wan is an accomplished inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches to drug delivery systems. His work aims to improve the efficacy of cancer therapies while minimizing side effects.

Latest Patents

Jiandi Wan holds a patent for a lung targeting dual drug delivery system. This invention addresses a critical need in cancer treatment, as the American Cancer Society estimated that in 2009, 1,479,350 new cancer cases would be diagnosed in the United States, with 219,440 being lung and bronchus related. The standard treatments for non-small cell lung cancer (NSCLC) include surgery, chemotherapy, radiation, laser, and photodynamic therapy, but these methods often yield poor results. The National Cancer Institute reports that the combined 5-year survival rate for various cancer stages is only 15 percent. Wan's dual drug delivery system selectively targets the lungs to deliver anti-cancer drugs, aiming to inhibit the formation of metastases while reducing toxicity to healthy tissues.

Career Highlights

Throughout his career, Jiandi Wan has worked with prestigious institutions such as Rutgers, the State University of New Jersey, and Princeton University. His research has focused on developing innovative solutions to complex medical challenges, particularly in oncology.

Collaborations

Jiandi Wan has collaborated with notable colleagues, including Robert K Prud'homme and Patrick J Sinko. These partnerships have contributed to the advancement of his research and the development of effective cancer treatment strategies.

Conclusion

Jiandi Wan's innovative work in developing a lung targeting dual drug delivery system represents a significant advancement in cancer treatment. His contributions have the potential to improve patient outcomes and reduce the side effects associated with traditional therapies.